Reported Earlier, PTC Therapeutics Prices $500M Of 0% Convertible Senior Notes Due 2031 At $107.48 Conversion Price, A 40% Premium, To Refinance 2026 Convertible Notes

Loading news article.

Reported Earlier, PTC Therapeutics Prices $500M Of 0% Convertible Senior Notes Due 2031 At $107.48 Conversion Price, A 40% Premium, To Refinance 2026 Convertible Notes | WAPE

Reported Earlier, PTC Therapeutics Prices $500M Of 0% Convertible Senior Notes Due 2031 At $107.48 Conversion Price, A 40% Premium, To Refinance 2026 Convertible Notes

Article summary

Related companies

Comments —